Lactozhinal vaginal capsules, # 14

Lactoginal caps.

vag.

No. 14

Name ENG

LACTOGINAL

Clinical and pharmacological group

A drug that regulates the balance of the vaginal microflora

ATX code

Lactobacillus

Dosage

Lyophilized culture of lactobacilli L. casei rhamnosus Doderleini at least 1x108 CFU of viable bacteria

Structure

Capsule content:

.Active substance:

Lyophilized culture of lactobacilli L. casei rhamnosus Doderleini

not less than 1x108 CFU of viable bacteria. Auxiliary substances: potato starch ~ 139.810 mg, lactose monohydrate ~ 74.676 mg, sodium glutamate ~ 15.345 mg, sodium thiosulfate ~ 91.388 mg, magnesium stearate 3.410 mg

.Shell: Gelatin.

.Transparent gelatin capsules of size 0", filled with powder of light yellow with brownish shade.

Indications

Restoration of normal vaginal microflora after antibacterial therapy for bacterial vaginosis

in preparation for planned gynecological operations

during prenatal preparation of pregnant women at risk of bacterial vaginosis.

Prevention of recurrence of vulvovaginal candidiasis (including exacerbation of recurrent vulvovaginal candidiasis) after local and / or systemic therapy with antifungal drugs.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

Lyophilized culture of lactobacilli Lactobacillus casei rhamnosus Doderleini

Contraindications

Hypersensitivity to drug components.

Vulvovaginal candidiasis ("thrush").

Children under 18 years of age (efficacy and safety have not been established).

Specifications

Scope of the drug

Gynecology

Release form

Capsules

Manufacturer country

France

Package quantity, pcs

14

Scope of application

obstetrics and gynecology

Minimum age from

18 years

Way of introduction

Vaginally

Vacation conditions

Without recipe

Brand name

Biose Industrie

The amount of the dosage form in the primary package

14 pcs.

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Eubiotic

Anatomical and therapeutic characteristics

G01AX14 Lactobacilli

Dosage form

Vaginal capsules

Expiration date in days

1095

Package weight, g

thirty

Category

:

Antibiotics

,

Antiseptics and disinfectants

,

Disinfectants

Mode of application

:

Method of application - intravaginally.

< br> Insert the capsule deep into the vagina, moisten it in a little water to accelerate the dissolution of the drug.

< br> Restoration of normal vaginal microflora after antibacterial therapy of bacterial vaginosis: one capsule in the morning and evening for 7 days or one capsule daily for 14 days. < br> In preparation for planned gynecological operations, prenatal preparation of pregnant women at risk of bacterial vaginosis: one capsule in the morning and evening for 7 days or one capsule daily for 14 days - as part of complex therapy. < br> The dosage regimen should be adjusted depending on the severity of the clinical effect.

Prevention of recurrence of vulvovaginal candidiasis (including exacerbation of recurrent vulvovaginal candidiasis) after local and / or systemic therapy with antifungal drugs: 1 capsule at night.

< br> The duration of drug therapy is determined by the doctor.

< br> The course of treatment should not exceed more than 21 days.

The question of conducting repeated courses is decided individually.

Dosage (volume) of the substance in the preparation

:

Lyophilized culture of lactobacilli L. casei rhamnosus Doderleini at least 1x10?

CFU of viable bacteria.

"